tiprankstipranks
Oncternal Therapeutics Inc (ONCT)
NASDAQ:ONCT

Oncternal Therapeutics Stock Price & Analysis

426 Followers

ONCT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.69 - $4.63
Previous Close$0.83
Volume519.11K
Average Volume (3M)451.37K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$21.26M
Total Debt (Recent Filing)$31.00K
P/E Ratio-1.0
Beta2.78
Next EarningsNov 10, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-0.79
Shares Outstanding53,211,909
R-Squared0.07
Standard Deviation0.29
10 Day Avg. Volume355,710
30 Day Avg. Volume451,365
P/B Ratio0.62
P/S RatioN/A
P/CF RatioN/A
P/FCF Ratio-1.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside806.45% Upside
Rating ConsensusStrong Buy
Alpha-0.02
Number of Analyst Covering3


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

ONCT FAQ

What was Oncternal Therapeutics’s price range in the past 12 months?
Oncternal Therapeutics lowest stock price was $0.69 and its highest was $4.63 in the past 12 months.
    What is Oncternal Therapeutics’s market cap?
    Currently, no data Available
    When is Oncternal Therapeutics’s upcoming earnings report date?
    Oncternal Therapeutics’s upcoming earnings report date is Nov 10, 2022 which is in 46 days.
      How were Oncternal Therapeutics’s earnings last quarter?
      Oncternal Therapeutics released its earnings results on Aug 09, 2022. The company reported -$0.23 earnings per share for the quarter, missing the consensus estimate of -$0.229 by -$0.001.
        Is Oncternal Therapeutics overvalued?
        According to Wall Street analysts Oncternal Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Oncternal Therapeutics pay dividends?
          Oncternal Therapeutics does not currently pay dividends.
          What is Oncternal Therapeutics’s EPS estimate?
          Oncternal Therapeutics’s EPS estimate is -$0.24.
            How many shares outstanding does Oncternal Therapeutics have?
            Oncternal Therapeutics has 53,211,910 shares outstanding.
              What happened to Oncternal Therapeutics’s price movement after its last earnings report?
              Oncternal Therapeutics reported an EPS of -$0.23 in its last earnings report, missing expectations of -$0.229. Following the earnings report the stock price went up 0.901%.
                Which hedge fund is a major shareholder of Oncternal Therapeutics?
                Currently, no hedge funds are holding shares in ONCT

                ---

                Oncternal Therapeutics Stock Analysis

                Smart ScoreNeutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10
                4
                The Oncternal Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Oncternal Therapeutics Inc

                Oncternal Therapeutics, Inc. is a clinical-stage oncology company, which develops a diverse pipeline of treatments for cancers with critically unmet medical need. Its focus is on drug development on promising yet untapped biological pathways implicated in cancer progression. The company was founded in 1997 and is headquartered in San Diego, CA.

                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                AbbVie
                Amgen
                Gilead Sciences
                Moderna
                Vertex Pharmaceuticals

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis